Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
09/2007
09/19/2007CN100338055C Carbamates of 2-heterocyclic-1, 2-ethanediols
09/19/2007CN100338045C Solidifiable composition containing thiazole functional group
09/19/2007CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
09/19/2007CN100338040C Xanthine oxidase inhibitors
09/19/2007CN100337545C Liquid formulations for dernal application in treatment of parasitic insects in animals
09/18/2007US7271283 High refractive index, UV-curable monomers and coating compositions prepared therefrom
09/18/2007US7271195 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
09/18/2007US7271186 glycylboronic acid transition state analogs; effective against class C beta -lactamase AmpC
09/18/2007US7271184 For controlling parasites on warm-blooded animals; veterinary medicine
09/18/2007US7271169 1,4-disubstituted piperazine compounds; for example 2-{4-[2-(acetylamino)-3-(2-methylbenzothiazol-5-yloxy)propyl]piperazinyl}-N-(3-phenylphenyl)acetamide; cardiovascular diseases such as arrhythmias, intermittent claudication, angina, congestive heart disease, diabetes, and myocardial infarction
09/18/2007US7270800 Imaging amyloid deposits in living patients, with an amyloid binding agents having radiolabeled iodine; radiotherapy
09/18/2007CA2416229C Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/18/2007CA2275764C Process for the preparation of heteroaryl-phenylalanines
09/18/2007CA2274177C Process for the preparation of thiazole derivatives
09/18/2007CA2243234C 5h-thiazolo[3,2-a]pyrimidine derivatives
09/18/2007CA2219983C Process for the preparation of an hiv protease inhibiting compound
09/13/2007WO2007103670A2 Novel compounds that are useful for improving pharmacokinetics
09/13/2007WO2007103550A2 Substituted aminothiazole derivatives with anti-hcv activity
09/13/2007WO2007102515A1 Phenylthiazole derivative
09/13/2007WO2007101935A2 Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same
09/13/2007WO2007082808A3 Thiazoles as 11 beta-hsd1 inhibitors
09/13/2007US20070213383 Sulfamic acid ester compounds useful in the inhibition of steroid sulphatase activity and aromatase activity
09/13/2007US20070213377 2-{4-[Ethyl-(thiazol-4-ylmethyl)-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; liver-X-receptor modulators; anticholesterol agents; antiinflammatory agents; atherosclerosis; dyslipidemia; antidiabetic agents; alzheimer's disease; sepsis; skin disorders; cognition modulators
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070213329 Sulphones which modulate the action of gammasecretase
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/13/2007CA2645072A1 Substituted aminothiazole derivatives with anti-hcv activity
09/13/2007CA2643694A1 Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same
09/12/2007EP1832586A1 Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas
09/12/2007EP1831165A1 4-aminopiperidine derivatives
09/12/2007EP1831158A1 Novel cyclohexane derivatives
09/12/2007EP1830846A2 Thiazolium compounds and uses thereof
09/12/2007EP1830837A2 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
09/12/2007EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
09/12/2007EP1030850B1 Azoline derivatives
09/12/2007EP1019358B2 3,3-diarylpropylamines , their use and preparation
09/12/2007CN101035795A Thiazolyl-dihydro indazoles
09/12/2007CN101035777A Modulators of hcv replication
09/12/2007CN101035775A New hydroxymethylbenzothiazoles amides
09/12/2007CN101035755A Method of deprotection
09/12/2007CN101035531A 卤代苯甲酰胺衍生物 Halogenated benzamide derivative
09/11/2007US7268135 Biaryl sulfonamides and methods for using same
09/11/2007US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/11/2007US7268095 Transition metal catalysts for (co) polymerizing of olefinic monomers
09/11/2007CA2318368C Novel tricyclic compound
09/11/2007CA2231975C Substituted amino compounds and their use as substances having an analgesic effect
09/11/2007CA2163175C Anti-viral aromatic o-alkylated oximes, ethers and thioethers
09/07/2007WO2007100165A1 New crystalline modifications and solvate
09/07/2007WO2007100161A1 Method for preferential production of geometric isomers and isolation method
09/07/2007WO2007100160A1 Acrylonitrile compounds
09/07/2007CA2642424A1 Primary amines as renin inhibitors
09/06/2007US20070208166 Tao Kinase Modulators And Method Of Use
09/06/2007US20070208068 Aqueous Composition Comprising Thiazole Derivative
09/06/2007US20070208066 ER-beta-selective ligands
09/06/2007US20070208065 Such as 5-[4-(1,1-dimethylethyl)phenyl]-N-hydroxy-4-phenyl-2-oxazolchexanamide which inhibits production of IL-6 and/or TNF alpha by inflammatory cytokines; inflammatory diseases, autoimmune diseases
09/06/2007US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators
09/06/2007US20070205388 Acidity and dissociation; stability, for doping polymers, as electrolytes in batteries
09/05/2007EP1829865A2 Chemical compounds
09/05/2007EP1829863A1 Arylalkanoic acid derivative
09/05/2007EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof
09/05/2007EP1828177A2 Novel mch receptor antagonists
09/05/2007EP1828154A1 Phenyl-piperazin methanone derivatives
09/05/2007EP1828153A1 N-(2-aminophenyl)-4-(5-((ethylamino)methyl)-1,3-thiazol-2-yl)benzamide and n-(2-aminophenyl)-4-(5-((isopropylamino)methyl)-1,3-thiazol-2-yl)benzamide as hdac inhibitors
09/05/2007EP1828152A2 Heterocyclic compounds as inhibitors of factor viia
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007EP1345598B1 The use of rosiglitazone for treating psychiatric disorders.
09/05/2007CN101031567A Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof
09/05/2007CN101031555A Thiazole derivative capable of vap-1 inhibitory activity
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN101031295A Medicinal composition for prevention or treatment of parasitic protozoan infection
09/05/2007CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods
09/05/2007CN101029033A Production of N-contained pentabasic heteroaromatic dimethyl ether
09/05/2007CN100335461C Arylsulfonanilide ureas
09/04/2007US7265246 7-Aminoakyl-2-arylcarbonylaminoindanes, e.g., 3-Fluorobiphenyl-4-carboxylic acid (R)-(6-((3-ethoxypropylamino)methyl)-2R-hydroxyindan-1-yl)amide; treatment of cognitive impairment associated with schizophrenia, Alzheimer's disease, and psychoses
09/04/2007US7265139 RXR activating molecules
09/04/2007US7265138 inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis
09/04/2007US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders
09/04/2007US7265134 Tyrosine kinase inhibitors
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
09/04/2007US7265109 Thiazole derivatives
09/04/2007US7264891 Stability, efficiency and color purity
08/2007
08/30/2007WO2007098356A1 Congeners of milnacipran as monoamine re-uptake
08/30/2007WO2007097992A2 Novel heterocyclic diphenyl ethers
08/30/2007WO2007097403A1 Remedy or preventive for digestive ulcer
08/30/2007WO2007096647A2 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
08/30/2007WO2006127503A3 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
08/30/2007US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
08/30/2007US20070203208 comprises a mixture of insecticides and fungicides; synergistic
08/30/2007US20070203207 Heteroaromatic glucokinase activators
08/30/2007US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol
08/30/2007US20070203198 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes
08/30/2007US20070203189 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases
08/30/2007US20070203155 Compounds And Compositions As Ppar Modulators
08/30/2007US20070203147 2-Aminothiazole Compounds Useful As Aspartyl Protease Inhibitors
08/30/2007CA2643670A1 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
08/30/2007CA2643272A1 Gent for treating or preventing digestive ulcer
08/30/2007CA2642650A1 Novel heterocyclic diphenyl ethers
08/29/2007EP1824836A2 2-alkyl-cycloalk(en)yl-carboxamides
08/29/2007EP1824835A1 Heteroaromatic glucokinase activators
08/29/2007EP1824834A1 Meta-substituted thiazolidinones, the production thereof and their use as medicaments